2nd Patent applies to infant apneic events
CONCORD, MA - Apr 16, 2019 - Today the US Patent and Trademark Office (USPTO) issued the 2nd patent for Prapela’s infant health-promoting technology. The new patent applies to infant apneic events which are common especially in premature newborns. Prapela, Inc. has exclusively licensed SVS for infant health from Harvard’s Office of Technology Development (OTD).
SVS is a gentle, random vibration that is sleep-cycle friendly and non-habit forming. Clinical studies demonstrate SVS can enhance the rhythmicity of infant breathing and improve relaxation. In a study published in Pediatrics, the Journal of the American Academy of Pediatrics (AAP), SVS was shown to significantly reduce apneic events in preterm infants.
Recently, Prapela’s SVS technology was awarded its first grant from the National Institutes of Health and was an award winner in the SW National Pediatric Device Consortium competition held at SXSW in Austin.